195 related articles for article (PubMed ID: 11475802)
1. [Issues in therapeutic drug monitoring evaluation].
Paintaud G; Le Guellec C; Furet Y; Autret-Leca E
Therapie; 2001; 56(3):245-9. PubMed ID: 11475802
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic drug monitoring and pharmacokinetic dose prediction methods.
Oellerich M
Wien Klin Wochenschr Suppl; 1992; 191():12-5. PubMed ID: 1509745
[TBL] [Abstract][Full Text] [Related]
3. Value of therapeutic drug monitoring in epilepsy.
Johannessen SI; Landmark CJ
Expert Rev Neurother; 2008 Jun; 8(6):929-39. PubMed ID: 18505358
[TBL] [Abstract][Full Text] [Related]
4. [TDM (therapeutic drug monitoring) for dosing theophylline].
Ueda W
Masui; 1991 Oct; 40(10):1536-41. PubMed ID: 1766103
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic drug monitoring of antiretroviral agents scenario.
Moltó J; Clotet B
J HIV Ther; 2004 Nov; 9(4):75-8. PubMed ID: 15731738
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic drug monitoring of cancer chemotherapy.
Alnaim L
J Oncol Pharm Pract; 2007 Dec; 13(4):207-21. PubMed ID: 18045780
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic drug monitoring in cancer chemotherapy.
Bach DM; Straseski JA; Clarke W
Bioanalysis; 2010 May; 2(5):863-79. PubMed ID: 21083218
[TBL] [Abstract][Full Text] [Related]
8. Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European consensus conference.
Wallemacq P; Armstrong VW; Brunet M; Haufroid V; Holt DW; Johnston A; Kuypers D; Le Meur Y; Marquet P; Oellerich M; Thervet E; Toenshoff B; Undre N; Weber LT; Westley IS; Mourad M
Ther Drug Monit; 2009 Apr; 31(2):139-52. PubMed ID: 19177031
[TBL] [Abstract][Full Text] [Related]
9. Optimizing the use of biomarkers, surrogate endpoints, and clinical endpoints for more efficient drug development.
Colburn WA
J Clin Pharmacol; 2000 Dec; 40(12 Pt 2):1419-27. PubMed ID: 11185662
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic drug monitoring in cancer--are we missing a trick?
Bardin C; Veal G; Paci A; Chatelut E; Astier A; Levêque D; Widmer N; Beijnen J
Eur J Cancer; 2014 Aug; 50(12):2005-9. PubMed ID: 24878063
[TBL] [Abstract][Full Text] [Related]
11. How to anticipate the assessment of the public health benefit of new medicines?
Massol J; Puech A; Boissel JP;
Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
[TBL] [Abstract][Full Text] [Related]
12. [Therapeutic monitoring: analytic, pharmacokinetic and clinical aspects].
Marquet P
Acta Clin Belg; 1999; 53 Suppl 1():2-12. PubMed ID: 10216973
[TBL] [Abstract][Full Text] [Related]
13. Relevance of assessing drug concentration exposure in pharmacogenetic and imaging studies.
Lotrich FE; Bies RR; Smith GS; Pollock BG
J Psychopharmacol; 2006 Jul; 20(4 Suppl):33-40. PubMed ID: 16785268
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacokinetics and therapeutic drug monitoring of anticancer agents].
Marquet P; Rousseau A
Bull Cancer; 2008 Oct; 95(10):903-9. PubMed ID: 19004719
[TBL] [Abstract][Full Text] [Related]
15. Current concepts in pharmacokinetics and their implications for clinical medicine.
Müller M; Müller-Zellenberg U; Hochhaus G; Derendorf H
Wien Klin Wochenschr; 2001 Aug; 113(15-16):566-72. PubMed ID: 11571833
[TBL] [Abstract][Full Text] [Related]
16. Which reliable pharmacodynamic breakpoint should be advised for ciprofloxacin monotherapy in the hospital setting? A TDM-based retrospective perspective.
Pea F; Poz D; Viale P; Pavan F; Furlanut M
J Antimicrob Chemother; 2006 Aug; 58(2):380-6. PubMed ID: 16735422
[TBL] [Abstract][Full Text] [Related]
17. Appropriateness of therapeutic drug monitoring for lithium.
Ratanajamit C; Soorapan S; Doang-ngern T; Waenwaisart W; Suwanchavalit L; Suwansiri S; Jantasaro S; Yanate I
J Med Assoc Thai; 2006 Nov; 89(11):1954-60. PubMed ID: 17205880
[TBL] [Abstract][Full Text] [Related]
18. [Functions of the 'Therapeutic Drug Monitoring (TDM)' Group of the French Society of Pharmacology].
Marquet P;
Therapie; 2001; 56(3):235-7. PubMed ID: 11475800
[TBL] [Abstract][Full Text] [Related]
19. [Therapeutic drug monitoring: clinical practice].
Widmer N; Werner D; Grouzmann E; Eap CB; Marchetti O; Fayet A; Csajka C; Decosterd LA; Buclin T
Rev Med Suisse; 2008 Jul; 4(165):1649-50, 1652-60. PubMed ID: 18767291
[TBL] [Abstract][Full Text] [Related]
20. Protease inhibitor plasma concentrations in HIV antiretroviral therapy.
Justesen US
Dan Med Bull; 2008 Nov; 55(4):165-85. PubMed ID: 19232158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
